@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-T1M8B8ZB-K mesh:pharmacologicalAction jvr:-RKGZF8PT-H .
jvr:-MWS0TH1Q-3 mesh:pharmacologicalAction jvr:-RKGZF8PT-H .
jvr:-RKGZF8PT-H
  skos:hiddenLabel "Thymoleptics"@en, "Thymoleptic"@en, "Thymoleptiques"@fr, "Thymo-analeptiques"@fr, "Thymoanaleptic"@en, "Thymoanaleptiques"@fr, "Thymoanaleptics"@en ;
  skos:altLabel "Médicaments antidépresseurs"@fr, "Antidepressant"@en, "Antidepressive Agent"@en, "Anti-dépresseurs"@fr, "Antidepressants"@en, "Antidepressant Drugs"@en, "Antidepressant Drug"@en, "Antidepressant Medication"@en, "Agents antidépresseurs"@fr ;
  mesh:allowableQualifier jvr:-L6C0XPHT-4, jvr:-T9HQD7ST-J, jvr:-HQRFT0C6-B, jvr:-XV06LPML-W, jvr:-Q3979798-W, jvr:-R3QWLHRG-V, jvr:-BT300B3G-Q, jvr:-D0F21513-5, jvr:-WK5F724J-1, jvr:-NB0XHT3S-N, jvr:-CB30NGKB-3, jvr:-NKM836P1-M, jvr:-H7K65Q8S-Z, jvr:-SBNWSM1T-R, jvr:-NHL3D2X0-S, jvr:-THHNVC7V-3, jvr:-TJHVZCRZ-0, jvr:-W6SQV79N-S, jvr:-S0CS1X5R-5, jvr:-NFTHND7Q-8, jvr:-G30ZJ446-J, jvr:-FWD2BGQ0-9 ;
  skos:definition "Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems."@en ;
  skos:related jvr:-C27HW0ZD-N, jvr:-BZMQ8D8V-M ;
  skos:prefLabel "Antidepressive Agents"@en, "Antidépresseurs"@fr ;
  dc:established "1966-01-01"^^xsd:date ;
  dc:created "1999-01-01"^^xsd:date ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D000928> ;
  skos:narrower jvr:-X5BRM0BB-H, jvr:-XR0VST6Z-2 ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-BLF9ZFQ5-X ;
  skos:inScheme jvr: ;
  dc:modified "2021-03-05"^^xsd:date .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-RQF0G2F1-K mesh:pharmacologicalAction jvr:-RKGZF8PT-H .
jvr:-NXWWV8XK-T mesh:pharmacologicalAction jvr:-RKGZF8PT-H .
jvr:-TRTQHQ0J-Z mesh:pharmacologicalAction jvr:-RKGZF8PT-H .
jvr:-BZMQ8D8V-M
  skos:prefLabel "Dépression"@fr, "Depression"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:related jvr:-RKGZF8PT-H .

jvr:-D5349TK1-9 mesh:pharmacologicalAction jvr:-RKGZF8PT-H .
jvr:-K32P5ZN6-N mesh:pharmacologicalAction jvr:-RKGZF8PT-H .
jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-SW147HNB-Q mesh:pharmacologicalAction jvr:-RKGZF8PT-H .
jvr:-KWRLGQ6C-4 mesh:pharmacologicalAction jvr:-RKGZF8PT-H .
jvr:-GWZ77Z2W-Q mesh:pharmacologicalAction jvr:-RKGZF8PT-H .
jvr:-C27HW0ZD-N
  skos:prefLabel "Monoamine Oxidase Inhibitors"@en, "Inhibiteurs de la monoamine oxydase"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:related jvr:-RKGZF8PT-H .

jvr:-PLD32M1D-2 mesh:pharmacologicalAction jvr:-RKGZF8PT-H .
jvr: a skos:ConceptScheme .
jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-BLF9ZFQ5-X
  skos:prefLabel "Psychoanaleptiques"@fr, "Psychotropic Drugs"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-RKGZF8PT-H .

jvr:-BF1TB0ZS-G mesh:pharmacologicalAction jvr:-RKGZF8PT-H .
jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-DBG587R2-R mesh:pharmacologicalAction jvr:-RKGZF8PT-H .
jvr:-KMCFB42H-L mesh:pharmacologicalAction jvr:-RKGZF8PT-H .
jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-X5BRM0BB-H
  skos:prefLabel "Antidépresseurs de seconde génération"@fr, "Antidepressive Agents, Second-Generation"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-RKGZF8PT-H .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-VB9HRMXM-N mesh:pharmacologicalAction jvr:-RKGZF8PT-H .
jvr:-TZS1GMMK-D mesh:pharmacologicalAction jvr:-RKGZF8PT-H .
jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-LBTXTN20-4 mesh:pharmacologicalAction jvr:-RKGZF8PT-H .
jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-PW0338JN-2 mesh:pharmacologicalAction jvr:-RKGZF8PT-H .
jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-S83KFDDL-2 mesh:pharmacologicalAction jvr:-RKGZF8PT-H .
jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-JR5CQLBC-K mesh:pharmacologicalAction jvr:-RKGZF8PT-H .
jvr:-V95JXDTF-G mesh:pharmacologicalAction jvr:-RKGZF8PT-H .
jvr:-CG47NWCP-J mesh:pharmacologicalAction jvr:-RKGZF8PT-H .
jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-B5V45KL2-R mesh:pharmacologicalAction jvr:-RKGZF8PT-H .
jvr:-XR0VST6Z-2
  skos:prefLabel "Antidépresseurs tricycliques"@fr, "Antidepressive Agents, Tricyclic"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-RKGZF8PT-H .

jvr:-B1HDPZRZ-W mesh:pharmacologicalAction jvr:-RKGZF8PT-H .
jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .